Eli Lilly addressed investors at a Morgan Stanley conference where its broader obesity initiative was highlighted.
Eli Lilly participated in a Morgan Stanley conference, during which the company pointed to a broadening focus on obesity across its pipeline and commercial efforts.
Further verified details from the company's remarks at the event were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
